Andreotti, Felicita
Dettaglio
Andreotti, Felicita
ROMA - Dipartimento di Scienze cardiovascolari e pneumologiche
Pubblicazioni
Risultati 1 - 20 di 111 (tempo di esecuzione: 0.0 secondi).
Data di pubblicazione | Titolo | Autore(i) | File | |
---|---|---|---|---|
1 | 2003 | The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? | Gaudino, Mario; Andreotti, Felicita; Zamparelli, Roberto; Di Castelnuovo, Augusto; Nasso, Giuseppe; Burzotta, Francesco; Iacoviello, Licia; Donati, Maria Benedetta; Schiavello, Rocco; Maseri, Attilio; Possati, Gianfederico | - |
2 | 2013 | 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology | Montalescot, G; Sechtem, U; Achenbach, S; Andreotti, Felicita; Arden, C; Budaj, A; Bugiardini, R; Crea, Filippo; Cuisset, T; Di Mario, C; Ferreira, Jr; Gersh, Bj; Gitt, Ak; Hulot, J; Marx, N; Opie, Lh; Pfisterer, M; Prescott, E; Ruschitzka, F; Sabaté, M; Senior, R; Taggart, Dp; Van Der Wall, Ee; Vrints, Cjm; Zamorano, Jl; Achenbach, S; Baumgartner, H; Bax, Jj; Bueno, H; Dean, V; Deaton, C; Erol, C; Fagard, R; Ferrari, R; Hasdai, D; Hoes, Aw; Kirchhof, P; Knuuti, J; Kolh, P; Lancellotti, P; Linhart, A; Nihoyannopoulos, P; Piepoli, Mf; Ponikowski, P; Sirnes, Pa; Tamargo, Jl; Tendera, M; Torbicki, A; Wijns, W; Windecker, S; Knuuti, J; Valgimigli, M; Bueno, H; Claeys, Mj; Donner Banzhoff, N; Erol, C; Frank, H; Funck Brentano, C; Gaemperli, O; Gonzalez Juanatey, Jr; Hamilos, M; Hasdai, D; Husted, S; James, Sk; Kervinen, K; Kolh, P; Kristensen, Sd; Lancellotti, P; Maggioni, Ap; Piepoli, Mf; Pries, Ar; Romeo, F; Rydén, L; Simoons, Ml; Sirnes, Pa; Steg, Pg; Timmis, A; Wijns, W; Windecker, S; Yildirir, A; Zamorano, Jl | - |
3 | 2016 | 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) | Roffi, M; Patrono, Carlo; Collet, J; Mueller, C; Valgimigli, M; Andreotti, Felicita; Bax, Jj; Borger, Ma; Brotons, C; Chew, Dp; Gencer, B; Hasenfuss, G; Kjeldsen, K; Lancellotti, P; Landmesser, U; Mehilli, J; Mukherjee, D; Storey, Rf; Windecker, S; Baumgartner, H; Gaemperli, O; Achenbach, S; Agewall, S; Badimon, L; Baigent, C; Bueno, H; Bugiardini, R; Carerj, S; Casselman, F; Cuisset, T; Erol, Ç; Fitzsimons, D; Halle, M; Hamm, C; Hildick Smith, D; Huber, K; Iliodromitis, E; James, S; Lewis, Bs; Lip, Gyh; Piepoli, Mf; Richter, D; Rosemann, T; Sechtem, U; Steg, Pg; Vrints, C; Luis Zamorano, J. | - |
4 | 2018 | 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS | Valgimigli, M.; Bueno, H.; Byrne, R. A.; Collet, J. -P.; Costa, F.; Jeppsson, A.; Kastrati, A.; Kolh, P.; Mauri, L.; Montalescot, G.; Neumann, F. -J.; Petricevic, M.; Roffi, M.; Steg, P. G.; Zamorano, J. L.; Levine, G. N.; Badimon, L.; Vranckx, P.; Agewall, S.; Andreotti, F.; Antman, E.; Barbato, E.; Bassand, J. -P.; Bugiardini, R.; Cikirikcioglu, M.; Cuisset, T.; De Bonis, M.; Delgado, V.; Fitzsimons, D.; Galie, N.; Gilard, M.; Hamm, C. W.; Ibanez, B.; James, S.; Knuuti, J.; Landmesser, U.; Leclercq, C.; Lettino, M.; Lip, G.; Piepoli, M. F.; Pierard, L.; Schwerzmann, M.; Sechtem, U.; Simpson, I. A.; Uva, M. S.; Stabile, E.; Storey, R. F.; Tendera, M.; Van De Werf, F.; Verheugt, F.; Aboyans, V.; Windecker, S.; Coca, A.; Coman, I. M.; Dean, V.; Delgado, V.; Gaemperli, O.; Hindricks, G.; Iung, B.; Juni, P.; Katus, H. A.; Lancellotti, P.; McDonagh, T.; Ponikowski, P.; Richter, D. J.; Shlyakhto, E.; Roithinger, F. X.; Aliyev, F.; Stelmashok, V.; Desmet, W.; Postadzhiyan, A.; Georghiou, G. P.; Motovska, Z.; Grove, E. L.; Marandi, T.; Kiviniemi, T.; Kedev, S.; Massberg, S.; Alexopoulos, D.; Kiss, R. G.; Gudmundsdottir, I. J.; McFadden, E. P.; Lev, E.; De Luca, L.; Sugraliyev, A.; Haliti, E.; Mirrakhimov, E.; Latkovskis, G.; Petrauskiene, B.; Huijnen, S.; Magri, C. J.; Cherradi, R.; Ten Berg, J. M.; Eritsland, J.; Budaj, A.; Aguiar, C. T.; Duplyakov, D.; Zavatta, M.; Antonijevic, N. M.; Fras, Z.; Montoliu, A. T.; Varenhorst, C.; Tsakiris, D.; Addad, F.; Aydogdu, S.; Parkhomenko, A.; Kinnaird, T. | riservato |
5 | 2003 | 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: A prospective study | Burzotta, F.; Iacoviello, L.; Di Castelnuovo, A.; Zamparelli, R.; D'Orazio, A.; Amore, C.; Schiavello, R.; Donati, M. B.; Maseri, A.; Possati, G.; Andreotti, F. | - |
6 | 1999 | A simple assay for platelet-mediated hemostasis in flowing whole blood (PFA-100): reproducibility and effects of sex and age. | Sestito, Alfonso; Sciahbasi, A; Landolfi, Raffaele; Maseri, A; Lanza, Gaetano Antonio; Andreotti, Felicita | - |
7 | 2012 | Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials | Navarese, Ep; Buffon, Antonino; Andreotti, Felicita; Gurbel, Pa; Kozinski, M; Kubica, A; Musumeci, G; Cremonesi, A; Tavazzi, L; Kubica, J; Castriota, F. | - |
8 | 2019 | Age-Related 2-Year Mortality After Transcatheter Aortic Valve Replacement: the YOUNG TAVR Registry | Navarese, E. P.; Andreotti, F.; Kolodziejczak, M.; Wanha, W.; Lauten, A.; Veulemans, V.; Frediani, L.; Kubica, J.; de Cillis, E.; Wojakowski, W.; Ochala, A.; Zeus, T.; Bortone, A.; Buffon, A.; Jung, C.; Pestrichella, V.; Gurbel, P. A. | - |
9 | 2021 | Aims: The ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation (ORIGAMI) study investigates the safety and efficacy of Edoxaban administered via PEG in patients with atrial fibrillation and a clinical indication for a long-term anticoagulation. Design: In this prospective, single-centre observational study, 12 PEG-treated patients with indication to anticoagulation will receive edoxaban via PEG and will be followed up to 6 months. Plasma antifactor Xa activity and edoxaban concentrations will be assessed. Thromboembolic (ischaemic stroke, systemic embolism, venous thromboembolism) and bleeding events (Bleeding Academic Research Consortium and Thrombolysis in Myocardial Infarction) will be recorded at 1 and 6 months. Preliminary results: A retrospective analysis of five atrial fibrillation cases undergoing PEG implantation at our Institution who received edoxaban via PEG showed plasma anti-FXa levels at a steady state of 146 ± 15 ng/ml, without major adverse event at a mean follow-up of 6 months. Conclusion: ORIGAMI prospectively investigates PEG-administration of edoxaban in PEG-treated patients requiring long-term anticoagulation. Our preliminary retrospective data support this route of DOAC administration. | 1, Domenico D'Amario; Galli, Mattia; Canonico, Francesco; Restivo, Attilio; Arcudi, Alessandra; Scacciavillani, Roberto; Cappannoli, Luigi; Riccioni, Maria Elena; Giuseppina Annetta, Maria; Di Stefano, Gaetano; Piccinni, Carlo; Vergallo, Rocco; Antonio Montone, Rocco; Maria Leone, Antonio; Niccoli, Giampaolo; Sabatelli, Mario; Antonelli, Massimo; Andreotti, Felicita; De Cristofaro, Raimondo; Crea, Filippo | - |
10 | 2017 | Anemia contributes to cardiovascular disease through reductions in nitric oxide | Andreotti, Felicita; Coluzzi, Giulio; Pafundi, Teodosio; Rio, Teresa; Navarese, Eliano Pio; Crea, Filippo; Pistolesi, Massimo; Maseri, Attilio; Hennekens, Charles H. | - |
11 | 2021 | Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine | Andreotti, Felicita; Maggioni, Aldo Pietro; Campeggi, Alice; Iervolino, Adelaide; Scambia, Giovanni; Massetti, Massimo | - |
12 | 2011 | Antiplatelet agents for the treatment and prevention of atherothrombosis | Patrono, Carlo; Andreotti, Felicita; Arnesen, H; Badimon, L; Baigent, C; Collet, J; De Caterina, R; Gulba, D; Huber, K; Husted, S; Kristensen, Sd; Morais, J; Neumann, F; Rasmussen, Lh; Siegbahn, A; Steg, P; Storey, Rf; Van De Werf, F; Verheugt, F. | - |
13 | 2018 | Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis | Rocca, Bianca; Fox, Keith A A; Ajjan, Ramzi A; Andreotti, Felicita; Baigent, Colin; Collet, Jean-Philippe; Grove, Erik L; Halvorsen, Sigrun; Huber, Kurt; Morais, João; Patrono, Carlo; Rubboli, Andrea; Seljeflot, Ingebjorg; Sibbing, Dirk; Siegbahn, Agneta; Ten Berg, Jurrien; Vilahur, Gemma; Verheugt, Freek W A; Wallentin, Lars; Weiss, Thomas W; Wojta, Johann; Storey, Robert F | - |
14 | 2013 | Antithrombotic therapy for patients with atrial fibrillation and atherothrombotic vascular disease: striking the right balance between efficacy and safety | Patrono, Carlo; Andreotti, Felicita | - |
15 | 2020 | Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis | Galli, M.; Andreotti, F.; D'Amario, D.; Vergallo, R.; Vescovo, G. M.; Giraldi, L.; Migliaro, S.; Ameri, P.; Porto, I.; Crea, F. | - |
16 | 2015 | Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis | Andreotti, Felicita; Rocca, Bianca; Husted, Steen; Ajjan, Ramzi A; Ten Berg, Jurrien; Cattaneo, Marco; Collet, Jean Philippe; De Caterina, Raffaele; Fox, Keith A. A; Halvorsen, Sigrun; Huber, Kurt; Hylek, Elaine M; Lip, Gregory Y. H; Montalescot, Gilles; Morais, Joao; Patrono, Carlo; Verheugt, Freek W. A; Wallentin, Lars; Weiss, Thomas W; Storey, Robert F. | - |
17 | 2017 | Aspirin and the prevention of a common disease: Colorectal cancer | Andreotti, Felicita; De Caterina, Raffaele; Crea, Filippo | - |
18 | 2018 | Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering a systematic review and meta-analysis | Navarese, E. P.; Robinson, J. G.; Kowalewski, M.; Kolodziejczak, M.; Andreotti, F.; Bliden, K.; Tantry, U.; Kubica, J.; Raggi, P.; Gurbel, P. A. | riservato |
19 | 2019 | Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: A review | Navarese, E. P.; Andreotti, F.; Raggi, P.; Kolodziejczak, M.; Buffon, A.; Bliden, K.; Tantry, U.; Kubica, J.; Sardella, G.; Lauten, A.; Agewall, S.; Gurbel, P. A.; Brouwer, M. A. | - |
20 | 2013 | Bedside monitoring of antiplatelet therapy for coronary stenting | De Caterina, Raffaele; Marchioli, Roberto; Andreotti, Felicita | - |